Improving the operational efficiency of Phase 2 and 3 trials
نویسندگان
چکیده
منابع مشابه
Improving the operational efficiency of Phase 2 and 3 trials
The period toward the end of patients' participation in late stage blinded clinical trials is highly resource intensive for the sponsor. Consider first a Phase 3 trial. If the trial is a success, the sponsor has to implement the next steps, which might be filing for approval of the drug with the US Food and Drug Administration (FDA). To shorten the time interval between trial completion and sub...
متن کاملImproving the Operational Efficiency of Public Transport
Improving the efficiency of public transport systems is a critical problem. In order to help implement strategies for improving efficiency, public transport managers and researchers need access to an upto-date information system that fully describes these strategies including data on their quantitative benefits. This research outlines a proposal for developing such a database and how it might b...
متن کاملassessment of the efficiency of s.p.g.c refineries using network dea
data envelopment analysis (dea) is a powerful tool for measuring relative efficiency of organizational units referred to as decision making units (dmus). in most cases dmus have network structures with internal linking activities. traditional dea models, however, consider dmus as black boxes with no regard to their linking activities and therefore do not provide decision makers with the reasons...
Improving and Maintaining the Operational Efficiency of a Semiconductor Equipment
The present work addresses an operational inefficiency problem at a semiconductor equipment manufacturing warehouse, Varian Semiconductors Associates and Equipment (VSEA). This problem is important because if unresolved, the warehouse is unable to meet the part delivery time target of 24 hours during the busy period. The downstream effects of the late part delivery are delayed production schedu...
متن کاملDiscounting phase 2 results when planning phase 3 clinical trials.
Sample size planning is an important design consideration for a phase 3 trial. In this paper, we consider how to improve this planning when using data from phase 2 trials. We use an approach based on the concept of assurance. We consider adjusting phase 2 results because of two possible sources of bias. The first source arises from selecting compounds with pre-specified favourable phase 2 resul...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Trials
سال: 2016
ISSN: 1745-6215
DOI: 10.1186/s13063-016-1465-3